MiMedx Group Inc news

   Watch this stock
Showing stories 1 - 10 of about 109   

Articles published

MDXG 10.84 -0.03 (-0.28%)
price chart
MiMedx down 5% on new Viceroy report of misconduct
Embattled MiMedx (MDXG -4.5%) slumps on lower-than-normal volume on the heels of a November report by Viceroy Research reiterating its accusations of corporate misconduct related sales to the Veterans Administration.
The Current Analyst Recommendations for Kimberly-Clark Corporation (KMB ...
Kimberly-Clark Corporation (NYSE:KMB) shares were trading lower by -0.81 percent ($-0.95) at $116.05 a piece in Wednesday's session.
Today Analysts Focus on Axalta Coating Systems Ltd. (AXTA), MiMedx Group, Inc ...
MiMedx Group, Inc. (NASDAQ:MDXG), maintained return on investment for the last twelve months at 24.92, higher than what Reuters data shows regarding industry's average.
MiMedx Group (MDXG) Says its Leadership Well Positioned in Light Of FDA New ...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, ...
Mimedx Group Inc (NASDAQ:MDXG) Fall's in Trading Today – Down $0.59  Highlight Press
The Fundamental Facts on MiMedx Group, Inc. (MDXG)
MiMedx Group, Inc. (NASDAQ:MDXG) is an interesting stock at present. Now trading with a market value of 1.16B, the company has a mix of catalysts and obstacles that spring from the nature of its operations.
Should You Buy MiMedx Group, Inc. (MDXG) or Accuray Incorporated (ARAY)?  Economic News
In Search of Profitable Stocks: MiMedx Group, Inc. (MDXG), The Western Union ...  USA Commerce Daily
MiMedx Group Inc (MDXG) Plunges 6.43% on November 20
MiMedx Group Inc (MDXG) had a rough trading day for Monday November 20 as shares tumbled 6.43%, or a loss of $-0.76 per share, to close at $11.06.
Reliable Long-term Trend to Profit From: MiMedx Group, Inc. (MDXG), Drive ...  StockNewsGazette
Analysts Predict MiMedx Group, Inc. (MDXG) Stock Can Get To A $2.03B Market Cap  AllStockNews
MiMedx Group (MDXG) Says it Added New Materials To Its Website Exposing ...
MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, ...
What Is Insider Trading Activity Like At MiMedx Group, Inc. (MDXG)?  Economic News
Analysts: MiMedx Group, Inc. (NASDAQ:MDXG) Market Cap To Touch $2.17B  AllStockNews
MiMedx Group Inc (MDXG) Plunges 8.12% on November 01
MiMedx Group Inc (MDXG) had a rough trading day for Wednesday November 01 as shares tumbled 8.12%, or a loss of $-1.03 per share, to close at $11.65.
MiMedx Group (MDXG) Settles Lawsuit with Halo Wound Solutions  StreetInsider.com
MiMedx CEO Replies to Fraudulent Information About The Company  PR Newswire (press release)
Taking a Look at the Data Behind MiMedx Group, Inc. (MDXG)
MiMedx Group, Inc. (MDXG) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment.
Should Investors Take a Bite out of MiMedx Group, Inc. (MDXG)?  Economic News
Dissecting the Numbers for MiMedx Group, Inc. (MDXG) and Amedica Corporation ...  StockNewsGazette
MiMedx Group's (MDXG) CEO Pete Petit on Q3 2017 Results - Earnings Call Transcript
Good day ladies and gentlemen, and welcome to the Q3 2017 MiMedx Group Inc's Earnings Conference Call. At this time, all participants are in a listen-only mode.